(Q74430268)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12106524%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

review article

1 reference

title

[Adherence to antiretroviral drug therapy. A systematic review] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12106524%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

Francesc Puigventós

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12106524%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Melcior Riera

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12106524%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Carla Delibes

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12106524%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

María Peñaranda

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12106524%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Laura de la Fuente

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12106524%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Assumpció Boronat

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12106524%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 June 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12106524%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12106524%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12106524%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12106524%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

130-137

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12106524%20AND%20SRC:MED&resulttype=core&format=json

The problem of non-compliance with drug therapy

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

[Treatment compliance: what do we know about Spain?]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Evaluation of adherence to a triple antiretroviral therapy in HIV-positive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Patient-reported nonadherence to HAART is related to protease inhibitor levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Value of patient self-report and plasma human immunodeficiency virus protease inhibitor level as markers of adherence to antiretroviral therapy: relationship to virologic response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Adherence to combination antiretroviral therapies in HIV patients of low health literacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Characterizing patterns of drug-taking behavior with a multiple drug regimen in an AIDS clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

The extent of non-adherence in a large AIDS clinical trial using plasma dideoxynucleoside concentrations as a marker

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the Multicenter AIDS Cohort Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Adherence and effectiveness of highly active antiretroviral therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

A comparison study of multiple measures of adherence to HIV protease inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, type 1: a cross-sectional study in a municipal hospital clinic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Prospective randomized two-Arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

An Observed Performance Test of Medication Management Ability in HIV: Relation to Neuropsychological Status and Medication Adherence Outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

A cohort study of drug users' compliance with zidovudine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

A randomised, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: the OzCombo1 study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AAC

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Predictors of undetectable HIV plasma viral load in 250 HIV-positive women receiving care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Psychiatric morbidity, illicit drug use and adherence to zidovudine (AZT) among injection drug users with HIV disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Analysis of the Discontinuation of Protease Inhibitor Therapy in Routine Clinical Practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Comparison of antiretroviral medication name recall and antiretroviral names on prescription container labels in a sample of drug users being treated for HIV/AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Congruence of three self-report measures of medication adherence among HIV patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Electronic compliance assessment of antifungal prophylaxis for human immunodeficiency virus-infected women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Sociodemographic and psychological variables influencing adherence to antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Predictors of self-reported adherence in persons living with HIV disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Developing a self-administered tool to predict adherence to antiretroviral therapy: design, method, and objectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Adherence to antiretroviral therapy by pregnant women infected with human immunodeficiency virus: a pharmacy claims-based analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Disease progression, adherence, and response to protease inhibitor therapy for HIV infection in an Urban Veterans Affairs Medical Center

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Enhancing adherence to combination antiretroviral therapy in non-adherent HIV-positive men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Acceptance and adherence with antiretroviral therapy among HIV-infected women in a correctional facility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Barriers to antiretroviral adherence among HIV-infected adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Long-term patient adherence to antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Factors associated with the response to antiretroviral therapy among HIV-infected patients with and without a history of injection drug use

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

The pills identification test: a tool to assess adherence to antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Barriers to adherence to highly active antiretroviral therapy as expressed by people living with HIV/AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Adherence to medication regimens among children with human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Stavudine, lamivudine and indinavir in drug abusing and non-drug abusing HIV-infected patients: adherence, side effects and efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

A randomized, comparative study of lamivudine plus stavudine, with indinavir or nelfinavir, in treatment-experienced HIV-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Adherence, side effects and efficacy of stavudine plus lamivudine plus nelfinavir in treatment-experienced HIV-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Adherence to antiretroviral therapy among HIV-infected methadone patients: effect of ongoing illicit drug use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Quality of life in patients with human immunodeficiency virus infection: impact of social support, coping style and hopelessness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Monitoring adherence to HIV therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Measuring medication adherence: is assessment of missed doses sufficient?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Efficacy of and adherence to highly active antiretroviral therapy in children infected with human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Adherence to antiretroviral medications in an inner-city population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Perceived compliance with AZT dosing among a sample of African-American drug users.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Adherence to triple therapy and viral load response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

Health beliefs and discontinuation of zidovudine therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973341-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-7753(02)73341-1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12106524%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference